Company: TACOW
Filing Date: 2025-10-29
Form Type: 8-K
Source: 0001829126-25-008500
Chunk: 0

Company: Berto Acquisition Corp.
Filing Date: 2025-10-29
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item       Regulation      

On
October 29, 2025, Berto Acquisition Corp., a special purpose acquisition company (“ Berto OnMed

No
assurances can be made that Berto and OnMed will successfully negotiate and enter into a definitive agreement, or that the proposed transaction
will be consummated on the terms or timeframe currently contemplated, or at all. Any transaction would be subject to the completion of
due diligence, the negotiation of a definitive agreement providing for the proposed business combination, satisfaction of the conditions
negotiated therein, board and equity holder approval, regulatory approvals, and other customary conditions.

The
information in this Item 7.01, including Exhibit 99.1, is furnished and shall not be deemed “filed” for purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the “ Exchange Act

Additional
Information and Where to Find It

If
a definitive agreement is entered into in connection with the proposed business combination, Berto or a newly formed holding company
will prepare a registration statement, including a proxy statement/prospectus, to be filed with the U. S. Securities and Exchange Commission
(“ SEC

Participants
in the Solicitation

OnMed
and Berto and their respective directors, executive officers and other members of their management and employees, under SEC rules, may
be deemed to be participants in the solicitation of proxies of Berto’s shareholders in connection with the proposed business combination.
Investors and security holders may obtain more detailed information regarding the names, affiliations and interests of Berto’s
directors and officers in Berto’s reports filed with the SEC. Information regarding the persons who may, under SEC rules, be deemed
participants in the solicitation of proxies to Berto’s shareholders in connection with the proposed business combination will be
set forth in the proxy statement/prospectus for the proposed business combination when available. Information concerning the interests
of OnMed’s and Berto’s participants in the solicitation, which may, in some cases, be different than those of their respective
equityholders generally, will be set forth in the proxy statement/prospectus relating to the proposed business combination when it becomes
available.

Forward-Looking
Statements: